Randomized, Open-Label Trial of Tacrolimus/Everolimus vs. Tacrolimus/Enteric-Coated Mycophenolate Sodium to Prevent Biopsy-Proven Acute Rejection and Chronic Allograft Injury in Adult, Primary Kidney Transplantation
Phase of Trial: Phase III
Latest Information Update: 19 Dec 2016
At a glance
- Drugs Everolimus (Primary) ; Methylprednisolone (Primary) ; Methylprednisolone (Primary) ; Mycophenolate mofetil (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 16 Sep 2012 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 16 Sep 2012 Planned initiation date changed from 1 Jul 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.
- 14 Sep 2012 New trial record